Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Brief Communication
  • Published:

Conformational inhibition of the hepatitis C virus internal ribosome entry site RNA

Abstract

The internal ribosome entry site (IRES), a highly conserved structured element of the hepatitis C virus (HCV) genomic RNA, is an attractive target for antiviral drugs. Here we show that benzimidazole inhibitors of the HCV replicon act by conformational induction of a widened interhelical angle in the IRES subdomain IIa, which facilitates the undocking of subdomain IIb from the ribosome and ultimately leads to inhibition of IRES-driven translation in HCV-infected cells.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: The HCV IRES RNA target.
Figure 2: Normalized FRET signal for titrations of Cy3/Cy5-labeled IIa-2 RNA with benzimidazole ligands in the presence of 2 mM Mg2+.
Figure 3: HCV translation inhibition by benzimidazole 1 in human Huh-7.5 cells.

Similar content being viewed by others

References

  1. Maheshwari, A., Ray, S. & Thuluvath, P.J. Lancet 372, 321–332 (2008).

    Article  Google Scholar 

  2. Ji, H., Fraser, C.S., Yu, Y., Leary, J. & Doudna, J.A. Proc. Natl. Acad. Sci. USA 101, 16990–16995 (2004).

    Article  CAS  Google Scholar 

  3. Pestova, T.V. et al. Proc. Natl. Acad. Sci. USA 98, 7029–7036 (2001).

    Article  CAS  Google Scholar 

  4. Otto, G.A. & Puglisi, J.D. Cell 119, 369–380 (2004).

    Article  CAS  Google Scholar 

  5. Brown, E.A., Zhang, H., Ping, L.H. & Lemon, S.M. Nucleic Acids Res. 20, 5041–5045 (1992).

    Article  CAS  Google Scholar 

  6. Kieft, J.S. et al. J. Mol. Biol. 292, 513–529 (1999).

    Article  CAS  Google Scholar 

  7. Lukavsky, P.J. Virus Res. 139, 166–171 (2009).

    Article  CAS  Google Scholar 

  8. Seth, P.P. et al. J. Med. Chem. 48, 7099–7102 (2005).

    Article  CAS  Google Scholar 

  9. Dibrov, S.M., Johnston-Cox, H., Weng, Y.H. & Hermann, T. Angew. Chem. Int. Edn Engl. 46, 226–229 (2007).

    Article  CAS  Google Scholar 

  10. Lukavsky, P.J., Kim, I., Otto, G.A. & Puglisi, J.D. Nat. Struct. Biol. 10, 1033–1038 (2003).

    Article  CAS  Google Scholar 

  11. Spahn, C.M. et al. Science 291, 1959–1962 (2001).

    Article  CAS  Google Scholar 

  12. Boehringer, D., Thermann, R., Ostareck-Lederer, A., Lewis, J.D. & Stark, H. Structure 13, 1695–1706 (2005).

    Article  CAS  Google Scholar 

  13. Wyles, D.L., Kaihara, K.A., Vaida, F. & Schooley, R.T. J. Virol. 81, 3005–3008 (2007).

    Article  CAS  Google Scholar 

  14. Blight, K.J., McKeating, J.A., Marcotrigiano, J. & Rice, C.M. J. Virol. 77, 3181–3190 (2003).

    Article  CAS  Google Scholar 

  15. Song, Y. et al. J. Virol. 80, 11579–11588 (2006).

    Article  CAS  Google Scholar 

  16. Hermann, T. Angew. Chem. Int. Edn Engl. 39, 1890–1904 (2000).

    Article  CAS  Google Scholar 

  17. Hermann, T. Curr. Opin. Struct. Biol. 15, 355–366 (2005).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank B. Ho and C. Higginson for help with compound synthesis. We acknowledge the kind gift of NS5B protein by Gilead Sciences. This work was supported in part by the US National Institutes of Health, grants R01 AI72012 (T.H.) and K08 AI069989 (D.L.W.).

Author information

Authors and Affiliations

Authors

Contributions

M.P.C. synthesized the IRES-binding benzimidazole inhibitors. S.D. synthesized NS5B inhibitors. S.M.D. participated in the design of the RNA FRET construct. J.P. performed biochemical experiments and was involved in concept development of the FRET assay. D.L.W. conceived and performed cell-based assays. T.H. conceived and supervised the project and wrote the manuscript. J.P., D.L.W. and T.H. were involved in the discussion and interpretation of the experimental data.

Corresponding author

Correspondence to Thomas Hermann.

Supplementary information

Supplementary Text and Figures

Supplementary Methods and Supplementary Results (PDF 373 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Parsons, J., Castaldi, M., Dutta, S. et al. Conformational inhibition of the hepatitis C virus internal ribosome entry site RNA. Nat Chem Biol 5, 823–825 (2009). https://doi.org/10.1038/nchembio.217

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nchembio.217

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing